A clinical trial to compare Insulin Lispro and Insulin Aspart for use in pumps in patients with Type 1 Diabetes Mellitus

Mise à jour : Il y a 4 ans
Référence : EUCTR2017-001162-21

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

1) Day 6 of 6 days of pump reservoir in-use of Humalog 6D was noninferior to Day 6 of 6 days of pump reservoir in-use of Aspart 6D with regards to 7-point daily mean self-monitored blood glucose (SMBG; margin = 0.6 mmol/L). 2) Day 6 of 6 days of pump reservoir in-use of Humalog 6D was noninferior to Day 2 of 2 days of pump reservoir in-use of Humalog 2D with regards to 7-point daily mean SMBG (margin = 0.6 mmol/L). 3)Day 6 of 6 days of pump reservoir in-use of Humalog 6D was superior to Day 6 of 6 days of pump reservoir in-use of Aspart 6D with regards to 7-point daily mean SMBG.


Critère d'inclusion

  • Type 1 diabetes mellitus

Liens